ClinicalTrials.gg
CompletedNCT06998849Updated May 31, 2025

The Impact of Intraoperative Change in the Body Temperature on the Perfusion Index

An observational study in Perfusion Index and Hypothermia; Anesthesia, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by Ain Shams University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
50
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about the impact of intraoperative change in temperature in adult patients undergoing surgeries under general anaesthesia. The main question it aims to answer is:

Is the change in core body temperature reflected by changes in the prfusion index? Patients' core temperature, peripheral temperature and perfusion indices will be recorded throughout the span of the procedure.

Read the detailed description

Perioperative hypothermia increases the risk of postoperative morbidity and mortality. Almost 50-90% of the patients experience perioperative hypothermia. This involves a decrease in core temperature to ≤ 36°C, which results in an increased rate of surgical site infection, haemorrhagic tendency, and ischemic heart disease, making it a serious perioperative complication.

Early hypothermia during general anaesthesia is mainly caused by the redistribution of body heat from the central to peripheral compartments, due to vasodilation following use of the anaesthetics. The degree of redistribution of body heat may be affected by the peripheral perfusion state, which differs across patients and results in a difference in gradient between temperature of the central and peripheral compartments. Low peripheral perfusion state can lead to low peripheral body temperature, thus lowering the overall core body temperature.

It was previously reported that the risk factors for intraoperative hypothermia are age, BMI, preoperative systolic blood pressure, heart rate, baseline core temperature, ASA-PS score, the type of anaesthesia and surgery, the duration of preparation and surgery, and ambient temperature.

Previous studies did not include the PI as a risk factor for intraoperative hypothermia. Therefore, further studies are needed to assess the relationship between PI and hypothermia to generate a more accurate predictive score of perioperative hypothermia.

02

Conditions studied

  • Perfusion Index
  • Hypothermia; Anesthesia

Browse trials for

Keywords

  • Cross sectional
  • Observational
  • Hypothermia
  • Anaesthesia
  • Anesthesia
  • General Anaesthesia
  • General Anesthesia
  • General surgery
03

In context

Hypothermia

502 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's enrollment of 50 is below the median of 97 across 128 observational studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,932 studies on the registry; 433 are open to participants now.

Of its 33 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing elective surgery under general anesthesia in the months between April 2024 and June 2024 at Ain Shams University Hospitals

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing elective surgery under general anaesthesia
  • Patients aged between 20 and 70 years old.

Exclusion criteria

Exclusion Criteria:

  • Patients who decline to give a written informed consent.
  • Patients with psychiatric disorders that lead to inability to cooperate, speak, or read.
  • BMI between \<20 kg/m2 or >35 kg/m2.
  • Patients undergoing emergency surgeries.
  • Patients with peripheral vascular disease or rheumatoid disease.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
50 participants (actual)
Patient registry
No

Groups and cohorts

  • Adult patients undergoing general surgery

    Adult patients undergoing elective general surgery

    Diagnostic Test: Perfusion index

Interventions

  • Diagnostic testPerfusion index

    The perfusion index (PI) is defined as the ratio of pulsatile light absorption to continuous light absorption, denoted as AC/DC. Initially used as a quality signal indicator in pulse oximetry, PI has increasingly been recognized for its potential in non-invasive hemodynamic monitoring. Since PI changes with peripheral blood flow, it may reflect peripheral temperature gradients and, consequently, thermoregulatory responses like peripheral vasoconstriction. Studies have reported that the core-to-peripheral temperature difference correlates with peripheral PI. The findings suggest that both peripheral and core temperatures contribute to the threshold for shivering and that PI reflects the vasoconstriction induced by thermoregulatory responses that precede shivering

06

What researchers measure

Primary outcomes

  1. To measure the change of PI associated with change in core and peripheral body temperatures as measured by the oropharyngeal probe and the pattern of this change

    The PI was recorded by attaching a sensor to the patient's finger (Ultralife Pulse Oximeter JPD-500D). The baseline body temperature (T1) was measured using a Granzia GT-3 Digital thermometer. Subsequently, the PI was recorded and assessed every 15 min until completion of the surgery.

    Time frame: Through study completion, 3 months from April 2024 to June 2024

Secondary outcomes

  1. To detect the change of PI with the change in temperature gradient (it is defined as the difference between the skin temperature and the core temperature)

    Time frame: Through study completion, 3 months from April 2024 to June 2024

  2. To detect the incidence of a low reading of PI and the increase in serum lactate level in an arterial blood gases sample.

    A baseline ABG (B1) was drawn, and serum lactate value was recorded. A follow up ABG (B2) was drawn at PI values \<0.2%, and serum lactate was recorded again.

    Time frame: Through study completion, 3 months from April 2024 to June 2024

07

Study locations

1 site
  • Ain Shams University
    Cairo, Abbassia 00202, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06998849
Responsible party
Sponsor
First posted
May 31, 2025
Start date
Apr 1, 2024
Primary completion
Jun 30, 2024
Completion
Aug 5, 2024
Last update
May 31, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion